Urovant Sciences Ltd (UROV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Operating Expenses | 31,469 | 19,128 | 9,435 | 4,970 | 3,466 |
| Operating Income | -31,469 | -19,128 | -9,435 | -4,970 | -3,466 |
| Other Income | 229 | 44 | 6 | 59 | -147 |
| Pre-tax Income | -31,240 | -19,085 | -9,429 | -4,911 | -3,612 |
| Income Tax | 55 | 11 | 22 | 2 | 2 |
| Net Income Continuous | -31,295 | -19,096 | -9,451 | -4,913 | -3,615 |
| Net Income | $-31,295 | $-19,096 | $-9,451 | $-4,913 | $-3,615 |
| EPS Basic Total Ops | -1.56 | -1.01 | -0.47 | -0.25 | -0.43 |
| EPS Basic Continuous Ops | -1.56 | -1.02 | -0.47 | -0.25 | -0.43 |
| EPS Diluted Total Ops | -1.56 | -1.01 | -0.47 | -0.25 | -0.43 |
| EPS Diluted Continuous Ops | -1.56 | -1.02 | -0.47 | -0.25 | -0.43 |
| EBITDA(a) | $-31,429 | $-19,128 | $-9,435 | $-4,970 | $-3,466 |